Nordea Investment Management AB Acquires New Stake in USANA Health Sciences Inc. (USNA)
Nordea Investment Management AB acquired a new position in shares of USANA Health Sciences Inc. (NYSE:USNA) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 5,092 shares of the company’s stock, valued at approximately $567,000.
A number of other hedge funds also recently bought and sold shares of the stock. Parametrica Management Ltd bought a new stake in USANA Health Sciences during the first quarter worth $410,000. AMP Capital Investors Ltd increased its stake in USANA Health Sciences by 108.5% in the first quarter. AMP Capital Investors Ltd now owns 3,459 shares of the company’s stock worth $413,000 after buying an additional 1,800 shares during the last quarter. Invictus RG increased its stake in USANA Health Sciences by 9,678.4% in the first quarter. Invictus RG now owns 3,618 shares of the company’s stock worth $439,000 after buying an additional 3,581 shares during the last quarter. Huntington Asset Advisors Inc. bought a new stake in USANA Health Sciences during the first quarter worth $443,000. Finally, Lazard Asset Management LLC bought a new stake in USANA Health Sciences during the first quarter worth $1,044,000. Institutional investors and hedge funds own 41.97% of the company’s stock.
Shares of USANA Health Sciences Inc. (NYSE:USNA) traded down 0.19% during mid-day trading on Friday, reaching $136.20. The company’s stock had a trading volume of 44,958 shares. The firm has a market cap of $1.64 billion, a price-to-earnings ratio of 17.95 and a beta of 1.16. USANA Health Sciences Inc. has a 12 month low of $92.00 and a 12 month high of $148.15. The company’s 50-day moving average is $136.16 and its 200 day moving average is $123.82.
USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, July 26th. The company reported $2.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.05 by $0.02. USANA Health Sciences had a net margin of 10.07% and a return on equity of 34.15%. The firm earned $258.50 million during the quarter, compared to the consensus estimate of $256.66 million. During the same period last year, the firm earned $1.92 EPS. The business’s quarterly revenue was up 10.8% compared to the same quarter last year. On average, equities analysts anticipate that USANA Health Sciences Inc. will post $8.10 EPS for the current year.
A number of analysts recently weighed in on USNA shares. DA Davidson increased their price objective on USANA Health Sciences from $135.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, July 28th. Zacks Investment Research upgraded USANA Health Sciences from a “hold” rating to a “strong-buy” rating and set a $158.00 price target for the company in a report on Saturday, July 30th. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $149.11.
In other news, major shareholder Global Ltd Gull sold 10,000 shares of USANA Health Sciences stock in a transaction on Wednesday, July 13th. The shares were sold at an average price of $118.96, for a total transaction of $1,189,600.00. Following the completion of the sale, the insider now directly owns 6,349,110 shares of the company’s stock, valued at approximately $755,290,125.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Kevin Guest sold 16,285 shares of USANA Health Sciences stock in a transaction on Monday, August 15th. The stock was sold at an average price of $131.08, for a total transaction of $2,134,637.80. Following the sale, the insider now directly owns 16,285 shares of the company’s stock, valued at $2,134,637.80. The disclosure for this sale can be found here. 57.00% of the stock is currently owned by company insiders.
About USANA Health Sciences
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. It operates as a direct selling company in approximately two geographic regions: Americas and Europe, and Asia Pacific, which includes approximately three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences Inc. (NYSE:USNA).
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.